MedPath

Comparison the effect of propofol with subcutaneous Sumatriptane in treatment of acute migraine headache

Not Applicable
Conditions
Migraine.
G43.0,G43.
Migraine without aura [common mMigrain)migrane with aura [classical migraine]igraine],
Registration Number
IRCT201008174583N1
Lead Sponsor
Shahid Sadoughi University of Medical Sciences-Yazd, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

all patients aged between 18 and 45 years old with acute migraine headache admitted in emergency department or pain clinic.
exclusion criteria are pregnancy; opium addiction; diastolic pressure greater than 105. Sign and symptoms of organic headache peripheral and coronary artery disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Headache severity. Timepoint: Before intervention; half an hour; one hour; and 2 hours after intervention. Method of measurement: Visual Analog Scale(VAS).
Secondary Outcome Measures
NameTimeMethod
Accompanying symptoms including nausea vomiting photophobia and phonophobia. Timepoint: Before, half an hour, and one hour after intervention. Method of measurement: Observation.;Drug side effects including hypotension; bradycardia; nausea; vertigo; paresthesia. Timepoint: After intervention. Method of measurement: Observation.
© Copyright 2025. All Rights Reserved by MedPath